- Home
- RCKY vs FENC Comparison
RCKY vs FENC Comparison
Compare RCKY & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- FENC
- Stock Information
- Founded
- RCKY 1932
- FENC 1996
- Country
- RCKY United States
- FENC United States
- Employees
- RCKY N/A
- FENC N/A
- Industry
- RCKY Shoe Manufacturing
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCKY Consumer Discretionary
- FENC Health Care
- Exchange
- RCKY Nasdaq
- FENC Nasdaq
- Market Cap
- RCKY 196.3M
- FENC 225.4M
- IPO Year
- RCKY 1993
- FENC 2001
- Fundamental
- Price
- RCKY $30.06
- FENC $8.94
- Analyst Decision
- RCKY Buy
- FENC Strong Buy
- Analyst Count
- RCKY 1
- FENC 2
- Target Price
- RCKY $40.00
- FENC $13.50
- AVG Volume (30 Days)
- RCKY 55.3K
- FENC 56.2K
- Earning Date
- RCKY 10-29-2025
- FENC 11-06-2025
- Dividend Yield
- RCKY 2.12%
- FENC N/A
- EPS Growth
- RCKY 24.23
- FENC N/A
- EPS
- RCKY 2.48
- FENC N/A
- Revenue
- RCKY $462,328,000.00
- FENC $33,302,000.00
- Revenue This Year
- RCKY $7.02
- FENC $0.96
- Revenue Next Year
- RCKY $3.96
- FENC $51.71
- P/E Ratio
- RCKY $11.78
- FENC N/A
- Revenue Growth
- RCKY N/A
- FENC N/A
- 52 Week Low
- RCKY $11.93
- FENC $3.96
- 52 Week High
- RCKY $33.04
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- RCKY 59.78
- FENC 50.67
- Support Level
- RCKY $28.64
- FENC $8.42
- Resistance Level
- RCKY $29.69
- FENC $9.11
- Average True Range (ATR)
- RCKY 0.90
- FENC 0.30
- MACD
- RCKY -0.15
- FENC -0.03
- Stochastic Oscillator
- RCKY 60.73
- FENC 42.29
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.